Every winter, the healthcare system in the UK becomes strained as viruses like Covid, Flu, Norovirus, RSV and HMPV become more prevalent. This research study hopes to help reduce the burden as we investigate the effectiveness of a vaccine for RSV & HMPV.
This study will investigate how effective the vaccine is at reducing the frequency of cases of RSV & HMPV in adult patients aged 60 years of age or older.
This study is open to anyone aged 60 or older who is in generally good health.
Other inclusion / exclusion criteria will apply and this will be discussed with you by one of our research team over the phone
Your participation in this study will last for around one year and will involve receiving the study vaccine, or a placebo. This study is placebo-controlled meaning 50% participants will receive the study treatment and 50% will receive a placebo to allow comparisons to be made.
Your participation will also involve visits to our clinic as well as phone calls with our study team throughout the course of the study
You will receive reimbursement for your study related expenses, such as visits to our clinic.
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
.jpg)
